- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: SPD465
Total 51 results
-
ShireWithdrawnAttention Deficit Hyperactivity DisorderUnited States
-
ShireTerminatedAttention Deficit Hyperactivity Disorder (ADHD)United States
-
ShireCompletedAttention Deficit Hyperactivity Disorder (ADHD)United States
-
ShireCompletedAttention Deficit Hyperactivity Disorder (ADHD)United States
-
Acacia Pharma LtdCompletedPostoperative Nausea and VomitingUnited States, Switzerland, Germany, France
-
ShireCompletedAttention Deficit Hyperactivity Disorder (ADHD)United States
-
ShireCompletedAttention Deficit Hyperactivity Disorder (ADHD)United States
-
ShireCompletedAttention Deficit Hyperactivity Disorder (ADHD)United States
-
Astellas Pharma Global Development, Inc.Seagen Inc.CompletedMetastatic Urothelial Cancer and Other Malignant Solid TumorsUnited States, Canada
-
ShireCompletedDiverticulitisNew Zealand, United States, United Kingdom, Sweden, Australia, Israel, India, Spain, Colombia, Argentina, France
-
ShireCompletedAttention Deficit Hyperactivity Disorder (ADHD)United States
-
ShireCompletedMajor Depressive DisorderUnited States, Chile, Australia, Argentina, United Kingdom
-
ShireTerminated
-
ShireCompletedDiverticulitisUnited States, Italy, Germany, Canada, Brazil, Romania, Netherlands, Finland, South Africa, Hungary
-
ShireCompletedSleep DeprivationUnited States
-
ShireCompletedAttention Deficit Hyperactivity Disorder (ADHD)United States
-
ShireCompletedChronic Kidney Disease | HyperphosphatemiaGermany, Argentina, Chile, Czechia, Hungary, Poland, Romania, Russian Federation, Turkey
-
ShireCompletedSchizophrenia and Predominant Negative SymptomsUnited States
-
ShireCompletedEssential Thrombocythemia (ET)Japan
-
ShireWithdrawnNegative Symptoms of Schizophrenia
-
ShireCompletedAttention-Deficit/Hyperactivity Disorder
-
ShireCompletedEssential Thrombocythemia (ET)Japan
-
ShireTerminated
-
ShireCompleted
-
ShireCompletedUlcerative ColitisUnited States, United Kingdom, Australia, Poland, Slovakia
-
ShireCompleted
-
ShireCompletedHealthyUnited States
-
ShireCompletedHealthy VolunteersUnited States
-
ShireCompletedUlcerative ColitisUnited States, Spain, Denmark, Korea, Republic of, Australia, Taiwan, Singapore, Sweden, Belgium, France, United Kingdom, Romania, New Zealand, India, Canada, South Africa, Brazil, Germany, Mexico, Hungary, Portugal, Chile, Netherlands and more
-
ShireCompletedADHD Specifically With Executive Function ImpairmentUnited States
-
ShireCompletedAttention-Deficit/Hyperactivity DisorderUnited States
-
ShireCompletedAttention Deficit Hyperactivity Disorder (ADHD)Germany, Italy, Poland, Spain, Romania, Belgium, Hungary, Netherlands, Sweden, United Kingdom
-
ShireCompletedBinge Eating DisorderUnited States
-
ShireCompletedBinge Eating DisorderSpain, United States, Germany
-
ShireCompletedBinge Eating DisorderUnited States, Spain, Germany, Canada, Sweden
-
ShireCompletedADHDGermany, Hungary, Italy, Poland, Sweden, United States, United Kingdom, Belgium, France
-
ShireCompletedMajor Depressive DisorderUnited States
-
ShireCompletedSchizophreniaUnited States
-
ShireCompletedAttention Deficit Hyperactivity Disorder (ADHD)United States
-
ShireWithdrawn
-
ShireCompletedBinge Eating DisorderUnited States, Germany
-
ShireCompletedBinge Eating DisorderUnited States, Spain, Germany, Sweden
-
ShireTerminated
-
ShireCompletedMajor Depressive DisorderUnited States, Spain, Canada, Puerto Rico, Croatia, Mexico
-
ShireCompletedPhase II Dose-Ranging Study in Subjects With Mild to Moderate Ulcerative Colitis Treated With SPD476Colitis, UlcerativeBelgium
-
ShireTerminatedMajor Depressive DisorderUnited States, Spain, Germany, Puerto Rico, Canada, Estonia, South Africa, Czechia, Finland, Chile, Hungary, Mexico, Poland, Romania
-
ShireCompletedAttention-deficit/Hyperactivity DisorderUnited States, Canada, Germany, Hungary, Sweden
-
ShireCompletedMajor Depressive DisorderUnited States, Germany, Sweden, Poland, South Africa, Belgium, Czechia, Estonia, Finland, Hungary, Romania
-
ShireCompletedAttention-deficit/Hyperactivity DisorderUnited States